STOCK TITAN

Proto Labs officer plans $446K share sale

The shares are attributed to restricted stock units that vested from February 13, 2023, through May 20, 2025.

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Proto Labs, Inc. officer Daniel Schumacher reported an intended sale of 5,000 common shares, with an aggregate market value of $445,650.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through the vesting of restricted stock units from February 13, 2023, through May 20, 2025. His reported prior three-month sales, each identified as a 10b5-1 sale, were 4,900 shares on September 17, 2026, and 100 shares on September 16, 2026.

Positive

  • None.

Negative

  • None.
Common shares intended for sale 5,000 shares Reported intended sale
Aggregate market value $445,650.00 For the 5,000 common shares intended for sale
Shares outstanding 23,921,897 shares Count listed in the sale information
Prior 10b5-1 sale 4,900 shares; $417,535.37 September 17, 2026
Prior 10b5-1 sale 100 shares; $8,500.00 September 16, 2026
restricted stock units financial
"acquired upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 regulatory
"10b5-1 Sales for DANIEL SCHUMACHER"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
aggregate market value financial
"Aggregate market value of securities to be sold"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PRLB shares does Daniel Schumacher plan to sell?

Daniel Schumacher's notice lists an intended sale of 5,000 common shares with an aggregate market value of $445,650.00 through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many PRLB shares did Daniel Schumacher report selling in the prior three months?

His reported sales were 4,900 shares on September 17, 2026, for $417,535.37, and 100 shares on September 16, 2026, for $8,500.00; both were identified as 10b5-1 sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading